London, United Kingdom, Monday 6 September 2004. New data from the first international prospective study of statin treatment in people with the metabolic syndrome demonstrate that CRESTOR TM ...

London, UK, 25 October 2004. New data presented today from several studies involving more than 5,000 patients provide further evidence of the outstanding efficacy of CRESTOR TM (rosuvastatin) in ...

The results of a clinical trial involving nearly 2,000 patients suggest that AstraZeneca’s Crestor is more effective in getting patients with high cholesterol to their treatment goals than two ...

AstraZeneca is continuing in its bid to claim market share in the highly competitive world of cholesterol-lowering medications, and yesterday unveiled new data showing its offering Crestor ...

Wilmington, DE - Well before its FDA approval in August, rosuvastatin (Crestor ®, AstraZeneca) had been primed to explode onto the statin market. Nicknamed the "gorilla statin," or the "super-statin," ...

London, UK - At the request of European regulatory authorities, AstraZeneca has strengthened the prescribing information for rosuvastatin (Crestor ®), warning against the use of the highest (40-mg) ...

Share on Pinterest Two widely used statins may be equally effective at preventing heart attacks and stroke. Willie B. Thomas/Getty Images Two major statins—rosuvastatin and atorvastatin—are equally ...

In a Press release, the drug company repeated the safety and efficacy of the drug. Laura Bradbard, an FDA spokeswoman, said that Crestor is both effective and safe and that all the scientific evidence ...

BOSTON, May 23-A new analysis of post-marketing safety reports suggests that patients using Crestor (rosuvastatin), a super-potent statin, are more likely to develop serious side effects than patients ...

Crestor logo image Crestor (rosuvastatin calcium; AstraZeneca) tablets have been approved for use in pediatric patients aged 7-17 years with homozygous familial hypercholesterolemia (HoFH) to reduce ...